Core Laboratories N.V. (CLB)
NYSE: CLB
· Real-Time Price · USD
11.89
0.46 (4.02%)
At close: Oct 15, 2025, 3:59 PM
Core Laboratories Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 523.85M | 509.79M | 489.74M | 470.25M |
Cost of Revenue | 435.48M | 415.74M | 410.82M | 386.41M |
Gross Profit | 88.37M | 94.05M | 78.92M | 83.84M |
Operating Income | 58.56M | 54.64M | 41.52M | 45.26M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | 46.19M | 41.21M | 29.95M | 36.11M |
Net Income | 31.4M | 36.67M | 19.45M | 19.73M |
Selling & General & Admin | 38.59M | 38.89M | 38.12M | 44.17M |
Research & Development | n/a | n/a | n/a | n/a |
Other Expenses | -8.78M | 515K | -722K | -5.59M |
Operating Expenses | 29.82M | 39.41M | 37.4M | 38.58M |
Interest Expense | 12.37M | 13.43M | 11.57M | 9.15M |
Selling & Marketing Expenses | n/a | -1.36M | n/a | n/a |
Cost & Expenses | 465.29M | 455.15M | 448.21M | 424.99M |
Income Tax Expense | 14.03M | 4.18M | 10.3M | 15.89M |
Shares Outstanding (Basic) | 46.9M | 46.68M | 46.33M | 46.01M |
Shares Outstanding (Diluted) | 47.69M | 47.52M | 46.81M | 46.69M |
EPS (Basic) | 0.67 | 0.79 | 0.42 | 0.43 |
EPS (Diluted) | 0.66 | 0.77 | 0.42 | 0.42 |
EBITDA | 73.27M | 70.42M | 58.69M | 63.78M |
EBIT | 58.56M | 54.64M | 41.52M | 45.26M |
Depreciation & Amortization | 14.95M | 15.78M | 17.16M | 18.52M |
Source: Financial Modeling Prep. Financial Sources.